91 related articles for article (PubMed ID: 11472755)
1. Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test.
Watts GF; Barrett PH; Marais AD; Dane-Stewart CA; Martins IJ; Dimmitt SB; Redgrave TG
Atherosclerosis; 2001 Aug; 157(2):519-23. PubMed ID: 11472755
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
Tremblay AJ; Lamarche B; Ruel I; Hogue JC; Bergeron J; Gagné C; Couture P
Atherosclerosis; 2004 Feb; 172(2):367-73. PubMed ID: 15019548
[TBL] [Abstract][Full Text] [Related]
3. Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity.
Watts GF; Chan DC; Barrett PH; Martins IJ; Redgrave TG
Clin Sci (Lond); 2001 Dec; 101(6):683-90. PubMed ID: 11724657
[TBL] [Abstract][Full Text] [Related]
4. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: study with artificial emulsions.
Carneiro MM; Miname MH; Gagliardi AC; Pereira C; Pereira AC; Krieger JE; Maranhão RC; Santos RD
Atherosclerosis; 2012 Mar; 221(1):268-74. PubMed ID: 22257824
[TBL] [Abstract][Full Text] [Related]
5. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia.
Cabezas MC; de Bruin TW; Westerveld HE; Meijer E; Erkelens DW
J Intern Med; 1998 Oct; 244(4):299-307. PubMed ID: 9797493
[TBL] [Abstract][Full Text] [Related]
6. Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Redgrave TG; Watts GF; Martins IJ; Barrett PH; Mamo JC; Dimmitt SB; Marais AD
J Lipid Res; 2001 May; 42(5):710-5. PubMed ID: 11352977
[TBL] [Abstract][Full Text] [Related]
7. Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
Dane-Stewart CA; Watts GF; Mamo JC; Barrett PH; Martins IJ; Dimmitt SB; Redgrave TG
Eur J Clin Invest; 2002 Jul; 32(7):493-9. PubMed ID: 12153549
[TBL] [Abstract][Full Text] [Related]
8. Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.
YU KC; Smith D; Yamamoto A; Kawaguchi A; Harada-Shiba M; Yamamura T; Mamo JC
Clin Sci (Lond); 1997 Feb; 92(2):197-203. PubMed ID: 9059322
[TBL] [Abstract][Full Text] [Related]
9. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus.
Dane-Stewart CA; Watts GF; Barrett PH; Stuckey BG; Mamo JC; Martins IJ; Redgrave TG
Clin Endocrinol (Oxf); 2003 Apr; 58(4):415-20. PubMed ID: 12641623
[TBL] [Abstract][Full Text] [Related]
10. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
Chan DC; Watts GF; Barrett PH; Martins IJ; James AP; Mamo JC; Mori TA; Redgrave TG
J Lipid Res; 2002 May; 43(5):706-12. PubMed ID: 11971941
[TBL] [Abstract][Full Text] [Related]
11. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia.
Mamo JC; Smith D; Yu KC; Kawaguchi A; Harada-Shiba M; Yamamura T; Yamamoto A
Eur J Clin Invest; 1998 May; 28(5):379-84. PubMed ID: 9650011
[TBL] [Abstract][Full Text] [Related]
14. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.
Rubinsztein DC; Cohen JC; Berger GM; van der Westhuyzen DR; Coetzee GA; Gevers W
J Clin Invest; 1990 Oct; 86(4):1306-12. PubMed ID: 2212015
[TBL] [Abstract][Full Text] [Related]
15. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor.
Bowler A; Redgrave TG; Mamo JC
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):381-6. PubMed ID: 2049068
[TBL] [Abstract][Full Text] [Related]
16. Clearance of chylomicron-like lipid emulsions is increased in normal rabbits but not in heterozygous Watanabe heritable hyperlipidaemic rabbits following treatment with cholestyramine or pravastatin.
Mamo JC; Bowler A; Redgrave TG; Elsegood CL
Clin Exp Pharmacol Physiol; 1994 Sep; 21(9):687-94. PubMed ID: 7820948
[TBL] [Abstract][Full Text] [Related]
17. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice.
Martins IJ; Hone E; Chi C; Seydel U; Martins RN; Redgrave TG
J Lipid Res; 2000 Feb; 41(2):205-13. PubMed ID: 10681404
[TBL] [Abstract][Full Text] [Related]
18. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
[TBL] [Abstract][Full Text] [Related]
19. Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test.
Martins IJ; Tran JM; Redgrave TG
J Nutr; 2002 Feb; 132(2):176-81. PubMed ID: 11823575
[TBL] [Abstract][Full Text] [Related]
20. Defective plasma clearance of chylomicron-like lipid emulsions in Watanabe heritable hyperlipidemic rabbits.
Mamo JC; Bowler A; Elsegood CL; Redgrave TG
Biochim Biophys Acta; 1991 Feb; 1081(3):241-5. PubMed ID: 1998743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
